This HTML5 document contains 14 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB05436/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB05436
rdf:type
n3:Drug
n3:description
A substance that is being studied in the prevention of oral mucositis in patients receiving radiation therapy or chemotherapy for head and neck cancer. It is an oral polymer matrix-based rinse formulation that contains N-acetylcysteine, an antioxidant amino acid derivative with antiinflammatory properties.
n3:group
investigational
n3:indication
Investigated for use/treatment in adverse effects (chemotherapy).
owl:sameAs
n8:DB05436
dcterms:title
RK-0202
adms:identifier
n6:DB05436
n3:mechanismOfAction
RK-0202, an oral rinse for the prevention and treatment of mucositis, is based on the company's ProGelz technology and is comprised of the potent antioxidant N-acetylcysteine in a polymer matrix.
n3:InChI
n4:271B43A4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B43A3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B43A0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B43A1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B43A2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B43A5-363D-11E5-9242-09173F13E4C5